Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6

BACKGROUND: Mesenchymal stem cells (MSCs) are promising tools for the treatment of human lung disease and other pathologies relevant to newborn medicine. Recent studies have established MSC exosomes (EXO), as one of the main therapeutic vectors of MSCs in mouse models of multifactorial chronic lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaubey, Sushma, Thueson, Sam, Ponnalagu, Devasena, Alam, Mohammad Afaque, Gheorghe, Ciprian P., Aghai, Zubair, Singh, Harpreet, Bhandari, Vineet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019224/
https://www.ncbi.nlm.nih.gov/pubmed/29941022
http://dx.doi.org/10.1186/s13287-018-0903-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019224/
https://www.ncbi.nlm.nih.gov/pubmed/29941022
http://dx.doi.org/10.1186/s13287-018-0903-4

Ejemplares similares